Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

1,694 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,694 results

Testing effectiveness (Phase 2)Study completedNCT00251537
What this trial is testing

A Pilot Study of LTB4 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
LTB4 Sweden AB 40
Large-scale testing (Phase 3)Study completedNCT00102960
What this trial is testing

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 377
Testing effectiveness (Phase 2)Ended earlyNCT00768989
What this trial is testing

Phase IIB Pilot of Atazanavir + Raltegravir

Who this might be right for
HIV
Bristol-Myers Squibb 167
Not applicableStudy completedNCT01049568
What this trial is testing

Cell Phone Reminders Intervention

Who this might be right for
HAART Non-AdherenceHIVHIV Infections
University of North Carolina, Chapel Hill 43
Post-approval studies (Phase 4)Study completedNCT03723525
What this trial is testing

Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals

Who this might be right for
HIV
National Centre for AIDs and STD Control, Nepal 1,073
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Post-approval studies (Phase 4)Study completedNCT04039217
What this trial is testing

Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM

Who this might be right for
ARTHIV
Emory University 20
Not applicableLooking for participantsNCT00404989
What this trial is testing

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

Who this might be right for
HIV InfectionsHepatitis B
Syneos Health 24,258
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Not applicableLooking for participantsNCT03296202
What this trial is testing

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

Who this might be right for
HIV InfectionsAntiretroviral Agents
University Hospital, Bordeaux 7,200
Post-approval studies (Phase 4)Study completedNCT00611039
What this trial is testing

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 30
Post-approval studies (Phase 4)UnknownNCT03858478
What this trial is testing

Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST

Who this might be right for
HIV Seropositivity
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 110
Not applicableStudy completedNCT01410058
What this trial is testing

Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction

Who this might be right for
HIV
University of Zimbabwe 19
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Not applicableStudy completedNCT02363387
What this trial is testing

Suppression of HIV 1 RNA in People Living With HIV

Who this might be right for
HIV
Johns Hopkins University 102
Post-approval studies (Phase 4)Ended earlyNCT00661349
What this trial is testing

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 9
Post-approval studies (Phase 4)Study completedNCT01192035
What this trial is testing

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Who this might be right for
HIV-1
University of Aarhus 400
Testing effectiveness (Phase 2)Looking for participantsNCT05300035
What this trial is testing

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

Who this might be right for
HIV/AIDS and Infections
ANRS, Emerging Infectious Diseases 69
Not applicableStudy completedNCT00002168
What this trial is testing

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Large-scale testing (Phase 3)Study completedNCT00234923
What this trial is testing

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Who this might be right for
HIV Infection
Abbott 138
Load More Results